Skip to main content

and
  1. Article

    Open Access

    The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug

    Rheumatoid Arthritis (RA) is one of the most common autoimmune diseases, affecting approximately 1% of the UK adult population. Patients suffer considerable pain, stiffness and swelling and can sustain various...

    Nuria C Navarro Coy, Sarah Brown, Ailsa Bosworth in BMC Musculoskeletal Disorders (2014)